DNA methylation alterations in grade II- and anaplastic pleomorphic xanthoastrocytoma
暂无分享,去创建一个
S. Ropero | M. Esteller | V. Rohde | R. Martínez | G. Schackert | F. Carmona | W. Paulus | M. Kirsch | M. Vizoso | A. Gómez | Alonso Barrantes | Javier Carmona
[1] A. Tamašauskas,et al. Promoter methylation of AREG, HOXA11, hMLH1, NDRG2, NPTX2 and Tes genes in glioblastoma , 2013, Journal of Neuro-Oncology.
[2] R. Barbella-Aponte,et al. Xantoastrocitoma pleomórfico con extensión intraventricular y transformación anaplásica en paciente adulto: caso clínico , 2012 .
[3] M. Esteller,et al. Epigenetic disruption of cadherin-11 in human cancer metastasis , 2012, The Journal of pathology.
[4] V. Deltuva,et al. MGMT, GATA6, CD81, DR4, and CASP8 gene promoter methylation in glioblastoma , 2012, BMC Cancer.
[5] R. Barbella-Aponte,et al. [Pleomorphic xanthoastrocytoma with intraventricular extension and anaplastic transformation in an adult patient: Case report]. , 2012, Neurocirugia.
[6] V. Deltuva,et al. MGMT, GATA6, CD81, DR4, and CASP8 gene promoter methylation in glioblastoma , 2012, BMC Cancer.
[7] M. J. van de Vijver,et al. Methylation of cancer-stem-cell-associated Wnt target genes predicts poor prognosis in colorectal cancer patients. , 2011, Cell stem cell.
[8] L. Morandi,et al. Assessment of MGMT promoter methylation status in pleomorphic xanthoastrocytoma , 2011, Journal of Neuro-Oncology.
[9] G. Reifenberger,et al. SOCS3 promoter methylation is mutually exclusive to EGFR amplification in gliomas and promotes glioma cell invasion through STAT3 and FAK activation , 2011, Acta Neuropathologica.
[10] M. Esteller,et al. Cancer epigenetics reaches mainstream oncology , 2011, Nature Medicine.
[11] Kirsten Schmieder,et al. Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma , 2011, Acta Neuropathologica.
[12] Jean-Yves Delattre,et al. Methylation profiling identifies 2 groups of gliomas according to their tumorigenesis. , 2011, Neuro-oncology.
[13] B. Kong,et al. Frequent hypermethylation and loss of heterozygosity of the testis derived transcript gene in ovarian cancer , 2010, Cancer science.
[14] M. Esteller,et al. DNA methylation in early neoplasia. , 2010, Cancer biomarkers : section A of Disease markers.
[15] Sarah Song,et al. Silencing of TESTIN by dense biallelic promoter methylation is the most common molecular event in childhood acute lymphoblastic leukaemia , 2010, Molecular Cancer.
[16] Miguel Alaminos,et al. A microarray-based DNA methylation study of glioblastoma multiforme , 2009, Epigenetics.
[17] C. Orellana,et al. Subtelomeric analysis of pediatric astrocytoma: subchromosomal instability is a distinctive feature of pleomorphic xanthoastrocytoma , 2009, Journal of Neuro-Oncology.
[18] Tchoyoson C. C. Lim,et al. Pleomorphic xanthoastrocytoma in elderly patients may portend a poor prognosis , 2008, Journal of Clinical Neuroscience.
[19] G. Reifenberger,et al. Hypermethylation and transcriptional downregulation of the CITED4 gene at 1p34.2 in oligodendroglial tumours with allelic losses on 1p and 19q , 2007, Oncogene.
[20] Gabriele Schackert,et al. CpG island promoter hypermethylation of the pro-apoptotic gene caspase-8 is a common hallmark of relapsed glioblastoma multiforme. , 2007, Carcinogenesis.
[21] Peter A. Jones,et al. The Epigenomics of Cancer , 2007, Cell.
[22] A. Hoischen,et al. Frequent loss of chromosome 9, homozygous CDKN2A/p14ARF/CDKN2B deletion and low TSC1 mRNA expression in pleomorphic xanthoastrocytomas , 2007, Oncogene.
[23] D. Louis,et al. Downregulation of RUNX3 and TES by hypermethylation in glioblastoma , 2007, Oncogene.
[24] J. Herman,et al. Frequent hypermethylation of the DNA repair gene MGMT in long-term survivors of glioblastoma multiforme , 2007, Journal of Neuro-Oncology.
[25] S. Vandenberg,et al. Genome-wide hypomethylation in human glioblastomas associated with specific copy number alteration, methylenetetrahydrofolate reductase allele status, and increased proliferation. , 2006, Cancer research.
[26] Y. Toyama,et al. Pleomorphic xanthoastrocytoma of the spinal cord. Case report. , 2006, Journal of neurosurgery. Spine.
[27] M. Esteller. Epigenetics provides a new generation of oncogenes and tumour-suppressor genes. , 2006, British journal of cancer.
[28] Miguel Alaminos,et al. EMP3, a myelin-related gene located in the critical 19q13.3 region, is epigenetically silenced and exhibits features of a candidate tumor suppressor in glioma and neuroblastoma. , 2005, Cancer research.
[29] O. Wiestler,et al. Epigenetic Silencing of the Protocadherin Family Member PCDH-γ-All in Astrocytomas , 2005 .
[30] O. Wiestler,et al. Epigenetic silencing of the protocadherin family member PCDH-gamma-A11 in astrocytomas. , 2005, Neoplasia.
[31] Erwin G. Van Meir,et al. Aberrant methylation and down-regulation of TMS1/ASC in human glioblastoma. , 2004, The American journal of pathology.
[32] R. Gil‐Gouveia,et al. Pleomorphic xanthoastrocytoma of the cerebellum: illustrated review , 2004, Acta Neurochirurgica.
[33] Luca Regli,et al. Clinical Trial Substantiates the Predictive Value of O-6-Methylguanine-DNA Methyltransferase Promoter Methylation in Glioblastoma Patients Treated with Temozolomide , 2004, Clinical Cancer Research.
[34] P. Kleihues,et al. Genetic alterations associated with the evolution and progression of astrocytic brain tumours , 2004, Virchows Archiv.
[35] Y. Tomizawa,et al. Epigenetic inactivation of RASSF1A candidate tumor suppressor gene at 3p21.3 in brain tumors , 2003, Oncogene.
[36] Peter Nürnberg,et al. Distinct methylation profiles of glioma subtypes , 2003, International journal of cancer.
[37] M. Alonso,et al. Aberrant promoter methylation of multiple genes in oligodendrogliomas and ependymomas. , 2003, Cancer Genetics and Cytogenetics.
[38] E. A. Stevens,et al. Composite Pleomorphic Xanthoastrocytoma-Ganglioglioma Presenting as a Suprasellar Mass: Case Report , 2003, Neurosurgery.
[39] Rachel Jones,et al. Behavioural genetics: Worms gang up on bacteria , 2002, Nature Reviews Genetics.
[40] Javier Benitez,et al. Cancer Epigenetics and Methylation , 2002, Science.
[41] H. Müller,et al. Mammalian Achaete Scute Homolog 2 Is Expressed in the Adult Sciatic Nerve and Regulates the Expression of Krox24, Mob-1, CXCR4, and p57kip2 in Schwann Cells , 2002, The Journal of Neuroscience.
[42] Peter A. Jones,et al. The fundamental role of epigenetic events in cancer , 2002, Nature Reviews Genetics.
[43] G. Reifenberger,et al. The WHO Classification of Tumors of the Nervous System , 2002, Journal of neuropathology and experimental neurology.
[44] W. Farrell,et al. Preferential loss of Death Associated Protein kinase expression in invasive pituitary tumours is associated with either CpG island methylation or homozygous deletion , 2002, Oncogene.
[45] A. Hui,et al. Genetic imbalances in pleomorphic xanthoastrocytoma detected by comparative genomic hybridization and literature review. , 2002, Cancer genetics and cytogenetics.
[46] K. Koeller,et al. From the archives of the AFIP: superficial gliomas: radiologic-pathologic correlation. Armed Forces Institute of Pathology. , 2001, Radiographics : a review publication of the Radiological Society of North America, Inc.
[47] Mitsutoshi Nakamura,et al. Frequent Alterations of the p14ARF and p16INK4a Genes in Primary Central Nervous System Lymphomas , 2001 .
[48] J. Herman,et al. A gene hypermethylation profile of human cancer. , 2001, Cancer research.
[49] H. Nakase,et al. Frequent alterations of the p14(ARF) and p16(INK4a) genes in primary central nervous system lymphomas. , 2001, Cancer research.
[50] K. Koeller,et al. From the archives of the AFIP: superficial gliomas: radiologic-pathologic correlation. Armed Forces Institute of Pathology. , 2001, Radiographics : a review publication of the Radiological Society of North America, Inc.
[51] D. Brat,et al. Pleomorphic xanthoastrocytoma , 1999 .
[52] J. Herman,et al. Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia. , 1999, Cancer research.
[53] J. Kononen,et al. Accumulation of genetic changes is associated with poor prognosis in grade II astrocytomas. , 1997, The American journal of pathology.
[54] B. Scheithauer,et al. Classification and Grading of Low‐Grade Astrocytic Tumors in Children , 1997, Brain pathology.
[55] P. Pahapill,et al. Pleomorphic xanthoastrocytoma: case report and analysis of the literature concerning the efficacy of resection and the significance of necrosis. , 1996, Neurosurgery.
[56] J. Rey,et al. Chromosomal composition of a series of 22 human low-grade gliomas. , 1987, Cancer genetics and cytogenetics.
[57] L. Eng,et al. Pleomorphic xanthoastrocytoma: A distinctive meningocerebral glioma of young subjects with relatively favorable prognosis A study of 12 cases , 1979, Cancer.